Keyphrases
Targeted Therapeutics
100%
Therapeutic Antibody
100%
High Affinity
100%
Multi-target
100%
Multiple Myeloma
100%
Cancer Cells
66%
Cell Surface
66%
Effectiveness Evaluation
33%
Quality of Life
33%
Therapeutic mAb
33%
Clinical Setting
33%
Acquired Resistance
33%
Industrial Setting
33%
Multiple Receptor
33%
Clinical Utility
33%
Antibody Targeting
33%
Clinical Outcomes
33%
Cancer Therapy Target
33%
Clinical Efficacy
33%
Receptor-interacting Protein Kinase 1 (RIPK1)
33%
MM Patients
33%
Commercial Market
33%
Clinically Significant
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Multiple Myeloma
100%
Receptor Protein
33%
Receptor
33%